Cost savings from Medicare Part D plan comparisons

被引:0
|
作者
O'Connell, Mary Beth [1 ,6 ]
Pelaccio, Karli [2 ,7 ]
Tabon, Patrick K. [3 ]
Rashid, Zenab [2 ]
Na, Sharon Y. [4 ]
Thomas, Hanadi [1 ,5 ]
机构
[1] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Pharm Practice Dept, Detroit, MI USA
[2] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Doctor Pharm Program, Detroit, MI USA
[3] Univ Southern Calif, Mann Sch Pharm & Pharmaceut Sci, Titus Family Dept Clin Pharm, Los Angeles, CA USA
[4] Univ Southern Calif, Mann Sch Pharm & Pharmaceut Sci, Doctor Pharm Program, Los Angeles, CA USA
[5] Merriman Drugs, Livonia, MI USA
[6] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Pharm Practice Dept, 259 Mack Ave, Detroit, MI 48201 USA
[7] Blue Cross Blue Shield Michigan, Detroit, MI USA
关键词
D O I
10.1111/jgs.18758
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:1275 / 1279
页数:5
相关论文
共 50 条
  • [1] Potential Cost Savings in Medicare Part D for Otolaryngologic Medications
    Om B. Tripathi
    Aman M. Patel
    Hassaam S. Choudhry
    David W. Wassef
    Paul T. Cowan
    Richard Chan Woo Park
    Andrey Filimonov
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2025, 77 (4) : 1969 - 1980
  • [2] Cost Minimization of Medicare Part D Prescription Drug Plan Expenditures
    Patel, Rajul A.
    Lipton, Helene Levens
    Cutler, Timothy W.
    Smith, Amanda R.
    Tsunoda, Shirley M.
    Stebbins, Marilyn R.
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (08): : 545 - 553
  • [3] COST SAVINGS FROM GENERIC PROTON PUMP INHIBITORS IN MEDICARE PART D FROM 2013-2016
    Read, Andrew J.
    Kurlander, Jacob E.
    Waljee, Akbar K.
    Saini, Sameer D.
    GASTROENTEROLOGY, 2019, 156 (06) : S260 - S260
  • [4] Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination
    Patel, Rajul A.
    Walberg, Mark P.
    Mai, Yvonne
    McElroy, Nataliya
    Mallya, Anil
    Kim, Aesun
    Seo, Justin
    Woelfel, Joseph A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (02) : 84 - 91
  • [5] Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company
    Lalani, Hussain S.
    Kesselheim, Aaron S.
    Rome, Benjamin N.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 1053 - 1055
  • [6] Cost savings impact of a pharmacist-initiated teleservice program for Medicare Part D reviews
    Massey, Colleen
    Aungst, Timothy Dy
    Evans, Paula
    Bartlett, Donna
    Silva, Matthew A.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (01) : 56 - 60
  • [7] Potential Cost Savings in Medicare Part D Across Gastroenterology: An Assessment of Alternative Drug Sourcing
    Bouvette, Christopher A.
    Bouvette, Max
    Yohannan, Bryce
    Rumman, Amir
    Ali, Ijlal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (04): : 764 - 767
  • [8] Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label
    Egilman, Alexander C.
    Kesselheim, Aaron S.
    Sarpatwari, Ameet
    Rome, Benjamin N.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : 833 - 835
  • [9] Plan selection in Medicare Part D: Evidence from administrative data
    Heiss, Florian
    Leive, Adam
    McFadden, Daniel
    Winter, Joachim
    JOURNAL OF HEALTH ECONOMICS, 2013, 32 (06) : 1325 - 1344
  • [10] Potential Savings in Medicare Part D for Common Urological Conditions
    Kirk, Peter S.
    Borza, Tudor
    Dupree, James M.
    Wei, John T.
    Ellimoottil, Chad
    Caram, Megan E. V.
    Burkhardt, Mary
    Heidelbaugh, Joel J.
    Hollenbeck, Brent K.
    Skolarus, Ted A.
    UROLOGY PRACTICE, 2018, 5 (05) : 351 - 358